SCHEMBL1415754

SCHEMBL1415754

CCCCCCCC(P)(c1ccccc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.40
EBP Q15125 1/20 0.40
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
GAA P10253 1/20 0.38
EGFR P00533 1/20 0.38
SCN5A Q14524 3/20 0.38
SCN9A Q15858 3/20 0.38
DNM1 Q05193 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
EPHX2 P34913 1/20 0.37
PKM P14618 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17529778 1.00 SIGMAR1 (0.40) SIGMAR1EBPCNR1CNR2GAA
SCHEMBL23581511 1.00 SIGMAR1 (0.40) SIGMAR1EBPCNR1CNR2GAA
SCHEMBL647077 1.00 SIGMAR1 (0.40) SIGMAR1EBPCNR1CNR2GAA
SCHEMBL8860222 0.98 SIGMAR1 (0.40) SIGMAR1EBPCNR1CNR2GAA
SCHEMBL5070186 0.92 KIF11 (0.41) SIGMAR1MEN1KMT2A
SCHEMBL14689566 0.84 SIGMAR1 (0.42) SIGMAR1EBPCNR1CNR2GAA
SCHEMBL647983 0.83 KCNN4 (0.41) SIGMAR1MEN1KMT2AMAPK1SMN1; SMN2
SCHEMBL11332829 0.79 SIGMAR1 (0.42) SIGMAR1EBPGAASCN5ASCN9A
SCHEMBL8978824 0.79 ESR1 (0.53) SIGMAR1EBPGAASCN5ASCN9A
SCHEMBL5868580 0.79 KIF11 (0.57) SIGMAR1EBPGAASCN5ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0174174-B1 A METHOD OF STABILISING HYDROXY-CONTAINING POLYMERS OF BUTADIENE OR SUBSTITUTED DERIVATIVES THEREOF ELF ATOCHEM S.A. (FR) 1990-05-23 EP claimed
US-4593128-A Using a di- or triphenylphosphine compound ATLANTIC RICHFIELD COMPANY (US) 1986-06-03 US claimed
EP-0174174-A2 A method of stabilising hydroxy-containing polymers of butadiene or substituted derivatives thereof ELF ATOCHEM S.A. (FR) 1986-03-12 EP claimed
CN-116829646-B Polycarbonate resin composition and molded article 帝人株式会社 2026-05-12 CN disclosed
US-20260092167-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF TEIJIN LIMITED (JP) 2026-04-02 US disclosed
US-20260008920-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF TEIJIN LIMITED (JP) 2026-01-08 US disclosed
EP-4667531-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF Teijin Limited (JP) 2025-12-24 EP disclosed
EP-4592353-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF Teijin Limited (JP) 2025-07-30 EP disclosed
CN-120019101-A Polycarbonate copolymer and molded article comprising the same 帝人株式会社 2025-05-16 CN disclosed
CN-119998398-A Aromatic polycarbonate resin composition and molded article thereof 帝人株式会社 2025-05-13 CN disclosed
US-20250122374-A1 FLAME-RETARDANT POLYCARBONATE RESIN COMPOSITION AND MOLDED PRODUCT THEREOF TEIJIN LIMITED (JP) 2025-04-17 US disclosed
EP-1882718-A1 POLYCARBONATE RESIN COMPOSITION Teijin Chemicals, Ltd. (JP) 2008-01-30 EP disclosed
US-20070257401-A1 Resin Composition and Flat Panel Display Fixing Frame TEIJIN CHEMICALS LTD. (JP) 2007-11-08 US disclosed
EP-1808462-A1 RESIN COMPOSITION AND FIXING FRAMES FOR FLAT-PANEL DISPLAYS Teijin Chemicals, Ltd. (JP) 2007-07-18 EP disclosed
US-7148313-B2 Polycarbonate resin composition and molded articles thereof TEIJIN CHEMICALS, LTD. (JP) 2006-12-12 US disclosed
US-20050215750-A1 Polycarbonate resin composition and molded articles thereof TEIJIN CHEMICALS, LTD. (JP) 2005-09-29 US disclosed
US-6232397-B1 Molding compounds consisting of a polycarbonate mixture and a siloxane reticular rubber BASF AKTIENGESELLSCHAFT (DE) 2001-05-15 US disclosed
EP-0174174-B1 A METHOD OF STABILISING HYDROXY-CONTAINING POLYMERS OF BUTADIENE OR SUBSTITUTED DERIVATIVES THEREOF ELF ATOCHEM S.A. (FR) 1990-05-23 EP disclosed
US-4593128-A Using a di- or triphenylphosphine compound ATLANTIC RICHFIELD COMPANY (US) 1986-06-03 US disclosed
EP-0174174-A2 A method of stabilising hydroxy-containing polymers of butadiene or substituted derivatives thereof ELF ATOCHEM S.A. (FR) 1986-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008920-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF NOP2, CCT2, RPL8 SIGMAR1 3742/4885EBP 647/4885CNR1 3916/4885
US-20260092167-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF PAH, SEM1, ASH2L SIGMAR1 3845/4885EBP 1321/4885CNR1 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.